U-Blot® Research Grade torutamigCat. No. WA3688Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade torutamigCat. No. WA3688
U-Blot® Research Grade TorudokimabCat. No. WA3687
U-Blot® Research Grade ToripalimabCat. No. WA3686
U-Blot® Research Grade TorapselCat. No. WA3685
U-Blot® Research Grade ToralizumabCat. No. WA3684
U-Blot® Research Grade tonobafusp alfaCat. No. WA3683
U-Blot® Research Grade TomuzotuximabCat. No. WA3682
U-Blot® Research Grade TomaralimabCat. No. WA3681
U-Blot® Research Grade tolododekin alfaCat. No. WA3680
U-Blot® Research Grade TocilizumabCat. No. WA3679
U-Blot® Research Grade TobevibartCat. No. WA3678
U-Blot® Research Grade TobemstomigCat. No. WA3677